1. Review obesity and diabetes trends and health disparities in the US 2. Review body image and perception differences by race/ethnicity 3. Describe best practices in the treatment of diabetes in African Americans 4. Examine the difference in HbA1c interpretations in African Americans and related clinical considerations

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines.

This talk will cover recent clinical trials presented at the ADA in 2019 that have an impact on the management of diabetes, such as cardiovascular outcomes trials and the first oral GLP-1 RA phase 3 data. The faculty will take you through the latest guidelines from the ADA regarding the management of type 2 diabetes and describe how recent clinical trial data has been integrated in to these guidelines. After this meeting review, you will be equipped to manage type 2 diabetes based on these guidelines. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020, and they are subject to change as new information is published.

During this clinical coffee break, Dr. M. Susan Burke, and Elizabeth Haftel, a clinical pharmacist and certified diabetes educator, will discuss practical strategies for using GLP-1 receptor agonists in your patients with diabetes. They will discuss how this class of medications can benefit certain patients. To illustrate the process, faculty will walk through a patient case. You will have the opportunity to engage with this activity, view resources and test your knowledge with interactive questions.

This talk will provide an opportunity for the learner to (anonymously) test his/her knowledge in the management of people with type 2 diabetes using cases and an ARS. The cases will also be used to illustrate the pathophysiology of type 2 diabetes and provide an opportunity for developing a practical approach to treating people with type 2 diabetes, utilizing the commonest and newest medications available. The cases will also help the learners use medications safely and understand advantages and disadvantages, and common side effects of each class of medication. Finally a practical approach to the initiation and intensification of basal insulin will be covered.

What do primary care providers need to know about wound care and the diabetic foot? Join infectious disease expert Richard Hamill, and internist Edward Lee Poythress, as they review important questions they get asked about these topics!

Join Dr. Sanjiv Chopra, hepatologist, author, speaker, and thought leader as he interviews his guest, Dr. Martin Abrahamson, endocrinologist and associate professor at Harvard Medical School as they discuss major advances in diabetes as well as the promise of stem cell treatment, diet and weight loss in patients with diabetes, and advances in continuous glucose monitoring. The pair will end their conversation discussing what they have learned from patients over the years.

Take part in this interactive educational activity on continuous glucose monitoring (CGM) tailored just for you! As the first of three modules CGM, this activity is engineered with adaptive learning technology to personalize your educational experience. This module will test your knowledge and provide unique feedback based on your question responses until you are answering confidently and correctly. Topics covered in this module include how to identify patients who would benefit from CGM (with a focus on people with type 2 diabetes), what type of CGM devices are currently available, and how to decide which CGM system is best for individual patients.

As the third of three modules on continuous glucose monitoring (CGM), this activity is engineered with adaptive learning technology to personalize your education. This module will test your knowledge and give you unique feedback based on your question responses until you are answering confidently and correctly. Using real patient case scenarios, this module will review ambulatory glucose profile (AGP) reports obtained from CGM devices and discuss how to apply their data in the management of diabetes (with a focus on type 2 diabetes).

Listen to this podcast for a concise summary of the latest clinical practice guidelines for identifying glycemic targets and managing T2DM in various patient populations including, older adults, individuals with increased cardiac or renal risk, and those at risk for hypoglycemic events.

Dr. Martin Abrahamson will review the pathophysiology of type 2 diabetes, discuss non-insulin treatments, and explore the most recent guidelines and recommendations for advancing treatment in people with type 2 diabetes to achieve glycemic goals. Dr. Frank Domino will then review a basic framework for counseling patients on weight loss, including a discussion of best evidence on diet, exercise, and appropriate use of medication. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/03/2020, and they are subject to change as new information is published.

An elevated fasting blood glucose (FBG) is the hall mark of prediabetes. Fasting blood glucose increases approximately 1 mg/dl per year as a prediabetic. While it can take years for a person to develop type 2 diabetes from prediabetes, weight gain, sedentary lifestyle, illness, or stress, can accelerate this process. This presentation will discuss the prevalence and progression of prediabetes, as well as the most effective strategies to prevent the development of type 2 diabetes.